Latest Asx News

Stockland announces a 9-cent unfranked dividend for the half-year ending December 2025, alongside a Dividend Reinvestment Plan priced at $5.47 per security. The DRP offers investors a 1% discount and new securities issued will rank equally from the issue date.

Scalare Partners reported a remarkable 231% revenue increase in Q2 FY26, driven by full integration of recent acquisitions and new ecosystem initiatives. The company also turned operating cashflow positive, signalling strong momentum ahead.

Ragusa Minerals has raised $600,000 through a private placement to fund exploration at its Purple Pansy Manganese-Gold Project in Arizona, supported strongly by existing shareholders.

Develop Global Limited reports strong December quarter progress with Woodlawn mine commissioning on track, a major contract win, and a significant value uplift at Sulphur Springs ahead of a mid-2026 investment decision.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Develop Global Limited reported a positive operating cash flow of AUD 18.8 million for the December 2025 quarter, maintaining robust liquidity despite significant investing and financing cash outflows.

Rapid Critical Metals has launched a comprehensive scoping study for its NSW silver projects, backed by promising drilling results and advanced ore-sorting technology.

29Metals Limited has initiated a fully underwritten $150 million entitlement offer at $0.40 per share, aiming to bolster its growth projects and operational recovery following seismic disruptions. The retail offer opens on 28 January and closes on 11 February 2026.

Advanced Metals has ramped up its drilling programs in Mexico and Australia, backed by a $13 million capital raise and strengthened leadership, positioning itself for significant resource growth in 2026.

Bioxyne Limited has posted a record $17.2 million in quarterly revenue for Q2 FY26, driven by strong growth in its cannabis and psychedelics segments alongside strategic international expansions.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Ore Resources Ltd has reported significant high-grade gold intercepts at its Miriam Project, extending mineralisation at Forrest to 850 metres. The company also secured binding options to acquire the Randalls Gold Project and raised A$7.5 million to fund its ambitious 2026 exploration plans.